Aktie A000520 SAMIL PHARMACEUTICAL CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Samil Pharmaceutical Co.,Ltd

Aktien

A000520

KR7000520007

A000520

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 01.07.2024 		% 5 Tage % 1. Jan.
8’220 KRW -0.60% Intraday Chart für Samil Pharmaceutical Co.,Ltd -3.07% +22.69%
14.05. Samil Pharmaceutical Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
14.03. Samil Pharmaceutical Co.,Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 12 billion in funding
Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 12 billion in funding
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on November 30, 2021, has expired with 125,939 shares, representing 0.99% for KRW 997.71 million.
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on October 5, 2021, has expired with 119,560 shares, representing 0.94% for KRW 996.5 million.
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 4 billion in funding
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 5 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A000520 Aktie
  4. Nachrichten Samil Pharmaceutical Co.,Ltd
  5. Andere Sprachen